Healthcare

Treatment.com AI Inc. (CSE: TRUE) Announces Binding Letter of Intent...

Highlights,Treatment.com AI to acquire Alea Health, enhancing AI-driven mental health care capabilities.,Alea Health’s AI platform optimizes patient e...

MindBio Therapeutics (CSE: MBIO) Reports Independent Safety Audit Su...

Highlights,MindBio Therapeutics reports no serious adverse events in its Phase 2B trials for depression and cancer-related distress.,The independent s...

Is Knight Therapeutics Facing Challenges In Market Performance?

Highlights:,Knight Therapeutics sees a slight dip in stock price.,The company has a market capitalization of C$576.90 million.,A decrease in trading v...

Will Oncolytics Biotech's Current Spending Stifle Its Progress?

Highlights:,Oncolytics Biotech faces a relatively short cash runway based on current burn rate.,Cash burn reduced by nearly 10% over the last year, si...

Could NorthWest Healthcare's Earnings Fall Short in the Coming Year?

Highlights:,National Bank Financial reduces FY2025 earnings per share estimate for NorthWest Healthcare Properties Real Estate Investment Trust.,New f...

Has Medexus Pharmaceuticals Reached Its Peak Amid Market Trends?

Highlights,Medexus Pharmaceuticals shows fluctuating stock performance over the past year.,The company has experienced significant price movement, ref...

How Will Voyageur Pharmaceuticals' New Capital Structure Impact Its...

Highlights,Voyageur Pharmaceuticals,(TSXV:VM),raises over $680,000 through warrant exercises.,The exercises involve more than 5.7 million share purcha...

What’s Behind the Recent Drop in Microbix Biosystems' Performance?

Highlights:,Microbix Biosystems stock decreased by approximately 3.8% on Friday.,The stock reached a value of C$0.50, with over 375,000 shares traded....

Why Are So Many Savaria Insiders Selling Stock Right Now?

Highlights:,Multiple insiders at Savaria Corporation sold a significant number of shares during the past year.,Insiders may sell their holdings for re...

What Does the Earnings Revision Mean for the Future of WELL Health T...

Highlights,Cormark revises FY2025 earnings forecast for WELL Health Technologies.,New forecast anticipates earnings of $0.13 per share, up from $0.11....

Is Delivra Health’s Market Position Creating Concerns?

Highlights,Delivra Health Brands Inc.,(TSXV:DHB),operates in the health and wellness sector, with a notably high price-to-earnings (P/E) ratio.,The co...

Can Spectral Medical Recover From Its Recent Losses

Highlights:,Spectral Medical's share price crosses above its 50-day moving average.,The company reported a quarterly loss and modest revenue figures.,...

DiagnaMed Holdings Corp. (CSE: DMED) Announces Strategic Collaborati...

Highlights,DiagnaMed partners with TerraVent to advance low-cost, carbon-zero hydrogen production.,The alliance combines innovative hydrogen extractio...

Could Kits Eyecare Ltd.'s Recent Stock Surge Signal Bigger Shifts fo...

Highlights:,Kits Eyecare Ltd.,(TSX:KITS),saw a 12% increase in stock value last week.,Insiders sold CA$14 million worth of stock over the past year.,T...

Is Merit Financial Group LLC’s Boost in Novo Nordisk A/S a Risky Str...

Highlights,Merit Financial Group LLC increased its holdings in Novo Nordisk A/S during the fourth quarter.,The firm acquired additional shares, bringi...

What Factors Are Influencing dentalcorp's Stock Performance?

Highlights,dentalcorp’s stock market capitalization stands at C$1.42 billion.,The company’s stock price has varied between C$5.92 and C$10.50 over the...

Are Medexus Pharmaceuticals’ Stock Movements Indicating Trouble Ahea...

Highlights:,Medexus Pharmaceuticals experiences a fluctuating stock price range.,Trading activity shows fluctuations near significant moving averages....

Why Did Microbix Biosystems Stock Surpass Its Moving Average?

Highlights:,Microbix Biosystems stock moved above its fifty-day moving average.,Trading volume showcased notable activity in recent sessions.,The comp...

Kits Eyecare Ltd. (TSX: KITS) Reports Preliminary Results for Q4 and...

Highlights,Total revenue growth of 42% year-over-year for Q4 2024, reaching $44.8 million.,Adjusted EBITDA for Q4 2024 exceeded 6% of total revenue, s...

Why Is Kneat.com’s Stock Surpassing Expectations This Week?

Highlights,com, Inc. stock reached a new 52-week high.,The firm operates with a notable debt-to-equity ratio.,The company's market capitalization exce...